EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder

Peter Jacoby iD, Eric D Marsh iD, Scott Demarest iD, Jacinta M Saldaris iD, Helen Leonard iD, Heather E Olson iD, Joni N Saby, Elia Pestana-Knight iD, Rajsekar Rajaraman iD, Dana Price iD, Judith Weisenberg iD, Bernhard Suter iD und 2 weitere

Brain and Behavior · 2025-11 · 15 (11)

DOI: 10.1002/brb3.71061 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Brain and Behavior, online erschienen am 14.11.2025. Verfasst von Peter Jacoby und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Child Health Research, The Kids Research Institute Australia, The University of Western Australia, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Severity of Illness Index, Spasms, Infantile, Epileptic Syndromes, Outcome Assessment, Health Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Stan Perron Charitable Foundation, Children's Hospital of Colorado Foundation, Ponzio Family Chair in Neurology Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CDKL5 deficiency disorder (CDD) is a rare developmental and epileptic encephalopathy (DEE) associated with multiple impairments and comorbidities. Outcome measures for disease‐modifying clinical trials for DEEs should measurably capture a spectrum of caregiver priorities and be externally validated.

Methods

The International CDKL5 Clinical Research Network was the data source for this observational study. A Structural Equation Model was constructed with latent, exogenous variables related to observed clinical features to calculate a global severity score from the following assessments: the CDKL5 Clinical Severity Assessment‐Clinician and ‐Caregiver, Communication and Symbolic Behavior Scales Developmental Profile Infant Toddler Checklist and the Sleep Disturbance Scale for Children. Quantitative EEG power was measured as a biomarker. The Quality of Life Inventory—Disability measured quality of life.

Results

Acceptable fit statistics for models were obtained using data from 206 subjects (median [range] age 6.8 [3 months to 40] years). Motor and communication measures were the most important weighted contributors to the global severity score which correlated well with the biomarker and quality of life to support external validation.

Conclusions

The resultant global severity score provided evidence that the assessments formed a coherent set of measures that reliably and meaningfully captured the diversity of severity in CDD. The models illustrated how the symptoms form a measurable network of relationships which may be suitable as an outcome measure for CDD and DEEs more broadly in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severity of Illness IndexSpasms, InfantileEpileptic SyndromesOutcome Assessment, Health CareSeizuresHumansInfantChild, PreschoolMaleFemaleChildAdultQuality of LifeAdolescentYoung AdultElectroencephalography

Stichwörter der Autor:innen

CDKL5 deficiency disorderbiomarkersepilepsyhealthcareoutcome assessmentquality of life

Autor:innen und Institutionen

  • Centre for Child Health Research, The Kids Research Institute Australia, The University of Western Australia, Perth, Western Australia, Australia.
  • Division of Child Neurology, Departments of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
  • Department of Pediatrics and Neurology, School of Medicine, University of Colorado, Precision Medicine Institute, Children's Hospital Colorado, Aurora, Colorado, United States.
  • Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, United States.
  • Cleveland Clinic Neurological Department, Epilepsy Center, Cleveland, Ohio, United States.
  • UCLA Mattel Children's Hospital, Los Angeles, California, United States.

ORCID-Profile: Peter Jacoby, Eric D Marsh, Scott Demarest, Jacinta M Saldaris, Helen Leonard, Heather E Olson, Elia Pestana-Knight, Rajsekar Rajaraman, Dana Price, Judith Weisenberg, Bernhard Suter, Jenny Downs, Tim A Benke

Förderung

  • NINDS NIH HHS
  • Stan Perron Charitable Foundation
  • Children's Hospital of Colorado Foundation, Ponzio Family Chair in Neurology Research
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Jacoby, P., Marsh, E. D., Demarest, S., Saldaris, J. M., Leonard, H., Olson, H. E., Saby, J. N., Pestana-Knight, E., Rajaraman, R., Price, D., Weisenberg, J., Suter, B., Downs, J., & Benke, T. A. (2025). Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder. Brain and Behavior, 15(11). https://doi.org/10.1002/brb3.71061

Vancouver

Jacoby P, Marsh ED, Demarest S, Saldaris JM, Leonard H, Olson HE, et al. Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder. Brain and Behavior. 2025;15(11). doi:10.1002/brb3.71061

BibTeX
@article{Jacoby2025,
  author = {Jacoby, Peter and Marsh, Eric D and Demarest, Scott and Saldaris, Jacinta M and Leonard, Helen and Olson, Heather E and Saby, Joni N and Pestana-Knight, Elia and Rajaraman, Rajsekar and Price, Dana and Weisenberg, Judith and Suter, Bernhard and Downs, Jenny and Benke, Tim A},
  title = {Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder},
  journal = {Brain and Behavior},
  year = {2025},
  volume = {15},
  number = {11},
  doi = {10.1002/brb3.71061}
}
Kostenlos starten →